SpringHill Management

Europe, Surrey, United Kingdom, Bramley

Description

SpringHill is a private equity fund management company specializing in early stage investments and development capital.

Investor Profile

SpringHill Management has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series F, Series C, Post Ipo Equity rounds (top funding stages).
Majority of deals are located in China, United States, India.
Strong thematic focus on Medical, Health Care, Pharmaceutical.

Stage Focus

Series F (40%)
Series C (40%)
Post Ipo Equity (20%)

Country Focus

China (60%)
United States (20%)
India (20%)

Industry Focus

Medical
Health Care
Pharmaceutical
Information Technology
Insurance
Insurtech
Mhealth
Biotechnology
Clinical Trials
Biopharma

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SpringHill Management frequently co-invest with?

OrbiMed

North America, New York, United States, New York

Co-Investments: 2

INCE Capital

Asia, Shandong, China, Pudong

Co-Investments: 2

CITIC Securities

CITIC Securities

Asia, Guangdong, China, Shenzhen

Co-Investments: 2

UOB Venture

Asia, Central Region, Singapore, Singapore

Co-Investments: 2

Superstring Capital

North America, New York, United States, New York

Co-Investments: 2

Hel Ved Capital

Hel Ved Capital

Asia, Hong Kong Island, Hong Kong, Hong Kong

Co-Investments: 2

Rock Springs Capital

Rock Springs Capital

North America, Maryland, United States, Baltimore

Co-Investments: 2

HongShan

Asia, Beijing, China, Beijing

Co-Investments: 2

B Capital

North America, California, United States, Manhattan Beach

Co-Investments: 2

Kun Ling Capital

Kun Ling Capital

Asia, Shanghai, China, Shanghai

Co-Investments: 2

What are some of recent deals done by SpringHill Management?

Miaoshou Doctor

Beijing, Beijing, China

Miaoshou Doctor is a health care platform that provides communication services between doctors and patients.

Health CareMedicalmHealth

Series FAug 4, 2021

Amount Raised: $231,971,916

Beijing Yuan Xin

Beijing, Beijing, China

Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.

Health CareInformation TechnologyInsuranceInsurTech

Series FAug 3, 2021

Amount Raised: $231,832,092

Shanghai, Shanghai, China

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.

BiopharmaMedicalPharmaceutical

Series CJul 10, 2021

Amount Raised: $50,000,000

Morrisville, North Carolina, United States

Clinipace is a clinical research firm that offers integrated clinical research services for biopharmaceutical and medical firms.

BiotechnologyClinical TrialsMedical

Series CJul 8, 2021

Amount Raised: $50,000,000

Marksans Pharma

Mumbai, Maharashtra, India

Marksans Pharma is a pharmaceutical company that actively deals in R&D and offers CRAMS to healthcare companies.

Health CareMedicalPharmaceutical

Post Ipo EquityFeb 1, 2005

Amount Raised: $4,993,674